Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics
Clinical trial NCT03002389 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03002389
- Sponsor
- University of Virginia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-05
- Primary completion
- 2023-12-31
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.